Sanofi American Depositary Receipt logo

Sanofi American Depositary Receipt (0A2V)

Market Closed
20 Feb, 15:30
$
47. 00
-0.03
-0.06%
$
- Market Cap
- P/E Ratio
8.15% Div Yield
1,667 Volume
- Eps
$ 47.03
Previous Close
Day Range
46.49 47.38
Year Range
44.6 60.08
Want to track 0A2V and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0A2V earnings report is expected in 58 days (23 Apr 2026)

Summary

0A2V closed Friday lower at $47, a decrease of 0.06% from Thursday's close, completing a monthly decrease of -2.08% or $1. Over the past 12 months, 0A2V stock lost -2.08%.
0A2V pays dividends to its shareholders, with the most recent payment made on Jun 06, 2024. The next estimated payment will be in 8 months ago on Jun 06, 2025 for a total of $2.03691.
The last earnings report, released on Jan 29, 2026, missed the consensus estimates by -0.85%. On average, the company has fell short of earnings expectations by -0.85%, based on the last three reports. The next scheduled earnings report is due on Apr 23, 2026.
The stock of the company had never split.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

0A2V Chart

Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions

Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions

Texas Attorney General Ken Paxton on Thursday sued Sanofi for allegedly "bribing" providers to prescribe its medications over alternatives.

Reuters | 4 days ago
Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees

Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees

French drugmaker Sanofi said on Monday it will expand its global capability centre (GCC) in the southern Indian city of Hyderabad, and increase its workforce to more than 4,500 employees.

Reuters | 1 week ago
SNY Stock Falls After Board Suddenly Makes Leadership Change

SNY Stock Falls After Board Suddenly Makes Leadership Change

Sanofi stock slides 4.5% after it decides not to renew CEO Paul Hudson's mandate and names Belen Garijo as successor amid investor skepticism.

Zacks | 1 week ago

Sanofi American Depositary Receipt (0A2V) FAQ

What is the stock price today?

The current price is $47.00.

On which exchange is it traded?

Sanofi American Depositary Receipt is listed on LSE.

What is its stock symbol?

The ticker symbol is 0A2V.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 8.15%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.07.

When is the next earnings date?

The next earnings report will release on Apr 23, 2026.

Has Sanofi American Depositary Receipt ever had a stock split?

No, there has never been a stock split.

Sanofi American Depositary Receipt Profile

Pharmaceuticals Industry
Healthcare Sector
François-Xavier Roger CEO
LSE Exchange
US80105N1054 ISIN
FR Country
82,878 Employees
- Last Dividend
30 Sep 2013 Last Split
- IPO Date

Overview

Sanofi is a global leader in healthcare, deeply engaged in the journey of pushing the boundaries of medicine to improve health outcomes across the world. Founded in 1973 and headquartered in Paris, France, the company has evolved its name from Sanofi-Aventis to Sanofi in May 2011, marking a milestone in its expansive history. With a robust presence in the United States, Europe, and various international markets, Sanofi undertakes the research, development, manufacture, and marketing of therapeutic solutions through a comprehensive portfolio segmented into Pharmaceuticals, Vaccines, and Consumer Healthcare. The company's dedication to innovation is underscored by its collaborations, including a notable one with GlaxoSmithKline for a Covid-19 vaccine and a research venture with Stanford University School of Medicine focused on immunology and inflammation. Furthermore, Sanofi's partnership with Prellis Biologics, Inc., showcases its commitment to exploring new horizons in healthcare solutions.

Products and Services

  • Specialty Care Products: Sanofi delivers cutting-edge treatments in various therapeutic areas. This includes human monoclonal antibodies, treatments for multiple sclerosis, neurology, inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders. These products underline Sanofi's commitment to addressing complex health conditions with innovative solutions.
  • Diabetes and Cardiovascular Products: The company offers a range of medicines for diabetes care, showcasing its role in battling this global epidemic. Additionally, it provides products for cardiovascular health, emphasizing the importance of managing heart-related conditions.
  • Vaccines: With an emphasis on public health, Sanofi supplies vaccines for poliomyelitis, pertussis, and Hib for children; influenza, adult boosters, meningitis, and vaccines for travel and endemic diseases for adults, highlighting its role in preventing infectious diseases across all age groups.
  • Consumer Healthcare: Beyond prescription medicines, Sanofi extends its healthcare solutions to over-the-counter products. This includes allergy relief, cough and cold therapies, pain management, liver care, products promoting physical and mental wellness, probiotics, digestive health, and nutritional products. The range also features daily body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and powders for eczema, catering to a wide array of consumer health needs.
  • Pharmaceutical Products and Vaccines in Development: Sanofi is actively involved in the development of new pharmaceuticals and vaccines, pointing to a future of continued innovation and enhanced healthcare solutions. This commitment to research and development ensures Sanofi remains at the forefront of addressing emerging health challenges.

Contact Information

Address: 54, Rue La BoEtie
Phone: 33 1 53 77 40 00